Overview

A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations

Status:
NOT_YET_RECRUITING
Trial end date:
2027-06-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the pharmacokinetic profile and safety of anaprazole sodium in adult subjects, particularly including the elderly and those with renal or hepatic impairment.
Phase:
PHASE4
Details
Lead Sponsor:
Xuanzhu Biopharmaceutical Co., Ltd.